The study is designed to compare the performance of the Ambu AuraGain Laryngeal Mask Airway and LMA Supreme in normal airway patients.
Ambu AuraGain Laryngeal Mask Airway is a newly designed supraglottic device. We design this study to test its clinical performance in normal airway patients, in comparison with LMA Supreme.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
100
ChineseAMS
Beijing, Beijing Municipality, China
RECRUITINGOropharyngeal leak pressure
The airway pressure at which an airway leak is observed after successful placement of the device
Time frame: Up to 1 minute after the time of confirmed device placement
Insertion time
Time needed to insert the device
Time frame: Up to 1 minute on each insertion attempt
Ease of insertion
Number of attempts to place the device
Time frame: Up to 1 minute on each insertion attempt
Fiberoptic Grade of Laryngeal View
Fiberoptic Grade of Laryngeal View through each device will be graded using a previously grading system
Time frame: Up to 1 minute after placement of device
Postoperative Complications
Patient will be evaluated for sore throat, dysphonia, stridor, dysphagia, blood stain on device
Time frame: 2 hours after removal of the device
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.